Soleus Capital Master Fund, L.P.

Holdings History for Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Symbol: TERN on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 212,710 shares
Security Ownership %: 0.2%

Soleus Capital Master Fund, L.P. ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)

12 Feb 2026 - Soleus Capital Master Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 212,710 shares of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN). This represents 0.2% ownership of the company. In their previous filing dated 11 Feb 2025, Soleus Capital Master Fund, L.P. had reported owning 8,142,500 shares, indicating a decrease of +97%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Soleus Capital Master Fund, L.P.	0.2%	-94%	$7,546,951	212,710	-7,929,790	-97%	$35.48	13G/A	31 Dec 2025	12 Feb 2026, 17:01
Soleus Capital Master Fund, L.P.	9.6%		$23,776,100	8,142,500			$2.92	13G/A	31 Dec 2024	11 Feb 2025, 16:00